Financial Examination Assistance Services (Request for Proposals)
Posted
Jul 22, 2026
Sep 25, 2026
Provision of staffing assistance for financial examinations.
Track open bid opportunities, contracts, public meetings, and key contacts for Maryland Insurance Administration.
Share your ICP and we will surface 10 ready-to-buy accounts using buying signals, competitor contracts, and procurement activity for free
See my top accountsActive opportunities open for bidding
Posted
Jul 22, 2026
Sep 25, 2026
Provision of staffing assistance for financial examinations.
Key metrics and characteristics
City
The city where this buyer is located.
Baltimore
County
The county where this buyer is located.
Baltimore
Address
Physical address of this buyer.
200 St Paul St #2700
Phone Number
Contact phone number for this buyer.
(410) 468-2000
Zip Code
Postal code for this buyer's location.
21202
Propensity to Spend
How likely this buyer is to spend on new technology based on operating budget trends.
AI Adoption Score
How likely this buyer is to adopt new AI technologies.
Startup Friendliness
How often this buyer champions startups and early adoption.
Latest Budget Year
Unlock to view
Operating Budget
Unlock to view
Includes fiscal year calendars, procurement complexity scores, and strategic insights.
Get alerted before the bid drops, know which RFPs to pursue, and generate compliant drafts with AI.
AI-ranked best-fit opportunities before bid boards
Auto-drafted, compliance-ready outlines & boilerplate
Competitor & pricing intel from past awards
Native sync to Salesforce & HubSpot
Board meetings and strategic plans from Maryland Insurance Administration
The meeting focused on defining specialty drugs and specialty pharmacy operations. Key discussions included the role of specialty pharmacies in providing complex patient care, the lack of a universal definition for specialty drugs, and concerns regarding the potential abuse of specialty drug classifications by Pharmacy Benefits Managers (PBMs). Participants discussed the need for objective criteria to identify drugs requiring special handling versus those that could be safely managed by retail pharmacies. There was also a proposal to invite third-party experts to provide an analysis of the drug supply chain and pricing.
The hearing addressed the affordability and availability of medical professional liability insurance in Maryland. Key topics included an overview of the Maryland Insurance Administration's regulatory role, licensing, and complaint processes. The discussion examined factors influencing insurance premiums, such as provider risk profiles and geographical location. Additionally, findings from the 2025 report were reviewed, highlighting market stability while noting the growing concentration of coverage within surplus lines and risk retention groups. Presentations further analyzed trends in medical malpractice claims, emphasizing the impact of rising claim severity and nuclear verdicts on the insurance landscape.
Public-sector contacts connected to Maryland Insurance Administration.
Get relevant Maryland Insurance Administration bid alerts
Track Maryland Insurance Administration bids, renewals, public meetings, and contact changes matched to what you sell.
The meeting focused on proposed regulations concerning the Mental Health Parity and Addiction Equity Act, particularly regarding amendments to section 15-144 of the insurance article. Discussions covered the evolution of federal and state parity laws, the implementation of comparative analysis requirements for non-quantitative treatment limitations, and new data collection standards for health insurance carriers. Stakeholders offered testimony on the necessity of pediatric-specific data for network adequacy, the importance of defining meaningful mental health benefits, and ensuring robust oversight of third-party administrators to prevent bias in access to care.
Extracted from official board minutes, strategic plans, and video transcripts.
Track Maryland Insurance Administration meetings, strategic plans, and budget discussions before the public bid appears.
Early signals from meeting minutes and plans
Vendor mentions and competitor tracking
Decision timeline from discussion to RFP
Quotable insights from buyer leadership